Greg Denomme

Dr. Greg Denomme, Director of Immunohematology and Transfusion Services at the Blood Center of Wisconsin, dives into the complexities of Hemolytic Disease of the Fetus and Newborn (HDFN). He clarifies the mechanisms behind maternal sensitization and the role of antibodies like anti-D and anti-K. Greg discusses historical advances in management, the significance of MCA Doppler in reducing invasive testing, and fetal genotyping techniques. Practical insights on handling low-risk antibodies and conservative management for anti-D are also highlighted, making HDFN both fascinating and crucial.